Nuchal translucency measurement
| Nuchal translucency measurement | |
|---|---|
| [[File:|250px|alt=|]] | |
| Pronunciation | |
| Synonyms | |
| Reference Range | |
| Calculator | |
| Purpose | Screening for chromosomal abnormalities |
| Test of | Fetus |
| Based on | Ultrasound |
| ICD-10-PCS | |
| ICD-9-CM | |
| MeSH | |
| OPS-301 Code | |
| Other Codes | |
| MedlinePlus | |
| eMedicine | |
| LOINC | |
| HCPCS-L2 | |
Nuchal Translucency Measurement is a prenatal screening test used to assess the risk of certain chromosomal abnormalities in a developing fetus. This test is typically performed during the first trimester of pregnancy, between 11 and 14 weeks of gestation.
Procedure[edit | edit source]
The nuchal translucency measurement is conducted using a specialized ultrasound technique. During the procedure, a trained sonographer measures the thickness of the nuchal translucency, which is the fluid-filled space at the back of the fetal neck. Increased thickness can be an indicator of potential chromosomal abnormalities such as Down syndrome (Trisomy 21), Trisomy 18, and Trisomy 13.
Indications[edit | edit source]
Nuchal translucency measurement is recommended for all pregnant women as part of routine prenatal screening. It is particularly advised for women who:
- Are 35 years of age or older
- Have a family history of chromosomal abnormalities
- Have had a previous pregnancy with a chromosomal abnormality
Interpretation of Results[edit | edit source]
The results of the nuchal translucency measurement are combined with other factors, such as maternal age and blood test results, to calculate the risk of chromosomal abnormalities. A higher than normal measurement may indicate an increased risk, prompting further diagnostic testing such as chorionic villus sampling (CVS) or amniocentesis.
Limitations[edit | edit source]
While nuchal translucency measurement is a useful screening tool, it is not diagnostic. It cannot definitively determine the presence of a chromosomal abnormality. False positives and false negatives can occur, and further testing is required to confirm any findings.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
